Benzinga's Top #PreMarket Losers
January 30, 2014 at 08:18 AM EST
KaloBios Pharmaceuticals (NASDAQ: KBIO ) dipped 30.97% to $3.21 in the pre-market session following poor Phase 2 study results from KB003. Citrix Systems (NASDAQ: CTXS ) shares fell 8.16% to $52.90 in the pre-market trading after the company issued a downbeat forecast. Baird downgraded the stock from Outperform